Non-natural carbon-linked nucleotides and dinucleotides
申请人:Mack Robert Stephen
公开号:US20050009777A1
公开(公告)日:2005-01-13
Nucleotide derivatives of formula (1) are described, wherein: G is a hydrogen atom or an optionally substituted aliphatic, heteroaliphatic, cycloaliphatic, polycycloaliphatic, aromatic or heteroaromatic group or a non natural carbon-linked nucleoside as defined herein; G′ is a non-natural carbon-linked nucleoside as defined herein; n is zero, or the integer 1 or 2; m is zero or the integer 1 or 2; and the salts, solvates, hydrates and N-oxides thereof. The compounds are P2Y receptor agonists and are of use in the prophylaxis and treatment of diseases and disorders involving abnormal secretory mechanisms such as inadequate functioning of mucociliary clearance mechanisms or abnormal tear secretion or in the treatment of diseases involving inappropriate cellular glucose uptake.
C nucleosides II. Preparation of 2-?-d-ribofuranosylbenzothiazole, 5-?-D-ribofuranosyltetrazole, and 5-?-glycosyl-1,3,4-oxadiazole derivatives
作者:I. Farkas、I. F. Szabo、R. Bognar、L. Sziladi
DOI:10.1007/bf00471634
日期:1978.7
Novel nucleotide triphosphates as potent P2Y2 agonists with enhanced stability over UTP
作者:Richard J. Davenport、Paloma Diaz、Frances C.A. Galvin、Steve Lloyd、Stephen R. Mack、Ray Owens、Verity Sabin、Joanne Wynn
DOI:10.1016/j.bmcl.2006.10.038
日期:2007.1
The synthesis of a series of novel C-linked nucleotidetriphosphates is reported. These exhibit excellent agonist potency and selectivity for the P2Y2 receptor with a number of examples having EC50 values below 10 nM. Representative compounds from the N-linked and C-linked series showed enhanced metabolic stability compared with that of the natural ligand UTP.